Literature DB >> 6826486

The penetration of amoxycillin/clavulanic acid into peritoneal fluid.

R Wise, I A Donovan, J Drumm, J M Andrews, P Stephenson.   

Abstract

Thirty patients undergoing elective abdominal surgery were given 1 g amoxycillin plus 0 . 2 g clavulanic acid as a single intravenous injection at varying times prior to the operation. Sterile assay discs were placed on the peritoneal surface in order to measure peritoneal fluid levels of each agent. Simultaneous serum levels were also measured. A total of 44 simultaneous serum and peritoneal samples were analysed. There was rapid penetration of both agents into peritoneal fluid. The mean peritoneal fluid levels of amoxycillin were 84% (S.D. 34) of the serum level and 66% 42) for clavulanic acid. The peritoneal levels of both agents declined in parallel to the serum levels (the half-lives all being about 1 h) and the ratio of amoxycillin: clavulanic acid in serum and peritoneal fluid was similar to that as administered.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6826486     DOI: 10.1093/jac/11.1.57

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Penetration of sulbactam-ampicillin and clavulanic acid-amoxicillin into the pelvic peritoneum.

Authors:  E T Houang; N Colley; M Chapman
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

2.  Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.

Authors:  R J Boon; A S Beale; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

3.  Penetration of sulbactam and ampicillin into peritoneal fluid.

Authors:  R Wise; I A Donovan; J M Andrews; J Drumm; S Bennett
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

4.  A randomised prospective controlled study of ciprofloxacin with metronidazole versus amoxicillin/clavulanic acid with metronidazole in the treatment of intra-abdominal infection.

Authors:  K Yoshioka; D J Youngs; M R Keighley
Journal:  Infection       Date:  1991 Jan-Feb       Impact factor: 3.553

Review 5.  Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.

Authors:  I D Watson; M J Stewart; D J Platt
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

Review 6.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

7.  Comparison of concentrations of two doses of clavulanic acid (200 and 400 milligrams) administered with amoxicillin (2,000 milligrams) in tissues of patients undergoing colorectal surgery.

Authors:  C Martin; M N Mallet; B Sastre; X Viviand; A Martin; P De Micco; F Gouin
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

8.  Experience with parenteral and sequential parenteral-oral amoxicillin/clavulanate (augmentin) in hospitalized patients.

Authors:  W Büchi; P A Casey
Journal:  Infection       Date:  1988 Sep-Oct       Impact factor: 3.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.